Matches in Wikidata for { <http://www.wikidata.org/entity/Q89155258> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q89155258 description "clinical trial" @default.
- Q89155258 description "ensayu clínicu" @default.
- Q89155258 description "klinisch onderzoek" @default.
- Q89155258 description "клінічне випробування" @default.
- Q89155258 description "կլինիկական փորձարկում" @default.
- Q89155258 name "Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal" @default.
- Q89155258 name "Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal" @default.
- Q89155258 type Item @default.
- Q89155258 label "Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal" @default.
- Q89155258 label "Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal" @default.
- Q89155258 prefLabel "Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal" @default.
- Q89155258 prefLabel "Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal" @default.
- Q89155258 P1132 Q89155258-479DC785-1B4B-4C8A-BC67-ECB11051A6EE @default.
- Q89155258 P1476 Q89155258-25D5BCC8-8059-4BDF-983B-9DFD96C32383 @default.
- Q89155258 P17 Q89155258-9EB49A34-FEF2-46F5-8DB4-014066DAC475 @default.
- Q89155258 P2899 Q89155258-E597CD98-D170-4DAC-8050-133139F378EF @default.
- Q89155258 P3098 Q89155258-DAFC6904-A557-4A6E-ADBF-18237CFFF961 @default.
- Q89155258 P31 Q89155258-5F78AD9F-357A-4B61-A59D-BA699B1F2FCE @default.
- Q89155258 P4135 Q89155258-2391B9C5-35B1-42CF-9ABB-6001030D42FE @default.
- Q89155258 P4844 Q89155258-4729F014-F961-40B7-90BA-BCE7F1716EA6 @default.
- Q89155258 P4844 Q89155258-80B0F8C9-37C1-4501-85E8-BB16548EF920 @default.
- Q89155258 P580 Q89155258-5D61C374-4CB9-4234-BEF4-9162AEA427F7 @default.
- Q89155258 P582 Q89155258-FC24A72F-9F9D-40B4-8A51-4DB1452C3684 @default.
- Q89155258 P6099 Q89155258-68188877-3ED5-4023-AAA9-135DFBF4E01A @default.
- Q89155258 P8363 Q89155258-7E5D08CD-5E14-4EF6-B685-A5130E733278 @default.
- Q89155258 P1132 "+168" @default.
- Q89155258 P1476 "Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy: a Multicenter, Phase II Trial" @default.
- Q89155258 P17 Q38 @default.
- Q89155258 P2899 "+18" @default.
- Q89155258 P3098 "NCT04318223" @default.
- Q89155258 P31 Q30612 @default.
- Q89155258 P4135 "+64" @default.
- Q89155258 P4844 Q15269707 @default.
- Q89155258 P4844 Q5508491 @default.
- Q89155258 P580 "2019-07-16T00:00:00Z" @default.
- Q89155258 P582 "2023-07-31T00:00:00Z" @default.
- Q89155258 P6099 Q42824440 @default.
- Q89155258 P8363 Q78089383 @default.